biomarker panel
AMLo Biosciences Gets UKCA Mark for Melanoma Biomarker Test
The test, which is marketed in the US by Avero Diagnostics, is designed to identify early-stage melanomas at low risk of progression.
Biocare Medical Acquires Empire Genomics
The company believes its existing technology portfolio will be complemented by Empire's molecular probe business, better aiding cancer research and diagnostics.
NCCN Publishes First Guidelines for Pediatric Brain Cancer, Recommends Broad NGS Profiling
The guidelines recognize the importance of molecular profiling in diagnosing, treating, and identifying clinical trial opportunities for children with high-grade gliomas.
Doctors, Payors, Lab Directors, Patients Have Distinct Views on What's Holding Up Precision Oncology
An AstraZeneca-funded survey suggests that efforts to improve precision oncology access must focus on bridging stakeholders' disagreements about the barriers limiting adoption.
Oncology Pharmacist Helps Boost Patient Enrollment at Community Practices Engaging in MYLUNG Study
When a trained pharmacist screened patients for eligibility, cancer practices were able to enroll nearly twice the number of participants each month than they were before this strategy was implemented.